Dutasteride Does Not Cause Bradycardia (Low Heart Rate)
Dutasteride is not associated with bradycardia or low heart rate based on FDA labeling and clinical trial data. Bradycardia is not listed as an adverse effect of dutasteride in any available evidence.
What the FDA Label Shows
The official FDA labeling for dutasteride 111 comprehensively lists adverse reactions from large clinical trials involving over 4,800 patients followed for up to 4 years. The documented adverse effects include:
- Sexual dysfunction (ejaculation disorders, impotence, decreased libido)
- Breast disorders (gynecomastia, breast tenderness)
- Dizziness (but not bradycardia)
- Cardiac failure (a numerical imbalance noted but no established causal relationship)
Notably absent from this extensive safety profile is any mention of bradycardia, heart rate changes, or chronotropic effects.
Cardiovascular Safety Profile
The cardiovascular concerns with dutasteride have centered on heart failure, not bradycardia. The FDA label 1 notes that in the CombAT trial, cardiac failure occurred in 0.7% of combination therapy patients versus 0.1% with dutasteride monotherapy, but explicitly states: "No causal relationship between dutasteride alone or in combination with tamsulosin and cardiac failure has been established" and "No imbalance was observed in the incidence of overall cardiovascular adverse events."
Large-scale research confirms this safety profile:
- A meta-analysis of 18,802 participants 2 found no increased risk of cardiovascular events with dutasteride
- A population-based cohort study of over 72,000 men 3 found no difference in cardiovascular events between dutasteride and finasteride
Why This Confusion May Arise
The 2018 ACC/AHA/HRS Bradycardia Guidelines 44 identify medications that commonly cause bradycardia, specifically listing:
- Beta blockers
- Calcium channel blockers
- Digoxin
- Sodium-channel and potassium-channel blocking antiarrhythmic drugs
Dutasteride is not mentioned in these guidelines as a cause of bradycardia. Dutasteride is a 5-alpha-reductase inhibitor that works by blocking conversion of testosterone to dihydrotestosterone—a completely different mechanism from drugs that affect cardiac conduction or heart rate.
Clinical Bottom Line
If a patient on dutasteride presents with bradycardia, look for the actual culprits per guideline recommendations 4:
- Review for negative chronotropic drugs (beta blockers, calcium channel blockers, digoxin)
- Assess for hypothyroidism
- Consider metabolic abnormalities (severe acidosis, hypokalemia)
- Evaluate for elevated intracranial pressure, acute MI, hypothermia, or obstructive sleep apnea
Do not attribute bradycardia to dutasteride—it is not a recognized adverse effect of this medication.